Results 111 to 120 of about 253,415 (210)

Sex-differential non-specific effects of adjuvanted and non-adjuvanted rabies vaccines versus placebo on all-cause mortality in dogs (NERVE-Dog study): a study protocol for a randomized controlled trial with a nested case-control study. [PDF]

BMC Vet Res, 2022
Knobel DL, Conan A, Toka FN, Arega SM, Byaruhanga C, Ogola E, Muok EMO, Crafford JE, Leisewitz AL, Quan M, Thrall MA.   +10 more
europepmc   +1 more source

Rabies and Rabies-Related Lyssaviruses [PDF]

, 2012
Rabies is a viral disease that affects the central nervous system (CNS) of mammals and has an extremely high case fatality rate. Once clinical signs develop, there are very few survivors.

core  

Short Term Safety, Immunogenicity, and Reproductive Effects of Combined Vaccination With Anti-GnRH (Gonacon) and Rabies Vaccines in Female Feral Cats. [PDF]

Front Vet Sci, 2021
Novak S, Yakobson B, Sorek S, Morgan L, Tal S, Nivy R, King R, Jaebker L, Eckery DC, Raz T.   +9 more
europepmc   +1 more source

β-Glucan as Trained Immunity-Based Adjuvants for Rabies Vaccines in Dogs. [PDF]

Front Immunol, 2020
Paris S, Chapat L, Martin-Cagnon N, Durand PY, Piney L, Cariou C, Bergamo P, Bonnet JM, Poulet H, Freyburger L, De Luca K.   +10 more
europepmc   +1 more source

Rabies vaccine : what you need to know [PDF]

1. What is rabies? -- 2. Rabies vaccine -- 3. Who should get rabies vaccine and when? -- 4. Tell your doctor if... -- 5. What are the risks from rabies vaccine? -- What if there is a serious reaction? -- 7.

core  

Inactivated rabies vaccines: Standardization of an in vitro assay for residual viable virus detection. [PDF]

PLoS Negl Trop Dis, 2020
Moreira BLC, Gimenez APL, Inagaki JMF, Raboni SM.   +3 more
europepmc   +1 more source

The efficacy of current rabies vaccines and novel Nanobody®-based antivirals against highly pathogenic phylogroup -1 and -2 members of the Lyssavirus genus

, 2010
Current rabies virus (RABV) vaccines and RABV immunoglobulins (RIG) confer protection against phylogroup 1 lyssaviruses. However, they offer partial or no protection against phylogroup 2 lyssaviruses and the high costs of such treatments, especially RIG,
van Gucht, S., Vaughan, A., de Haard, H.J., Hultberg, A., Koenders, M., Fooks, A.R., Verrips, T., Wright, E., Saunders, M., Rosseels, V., Weiss, R.A., Vanlandschoot, P.   +11 more
core  

Immunogenicity of Rabies Virus G-Protein mRNA Formulated with Muscle-Targeting Lipid Nanoparticles in Mice

Background: Rabies is a preventable zoonotic disease caused by the rabies virus (RABV) with a high mortality rate. Most vaccines on the market or under development have issues, such as low single-dose neutralization titer, complex processes, and high ...
Qin Li, Qiang Liu, Rongkuan Hu, Xueliang Yu, Huarong Bai   +4 more
core   +1 more source

Current laboratory techniques in rabies diagnosis, research and prevention.

Laboratory Techniques in Rabies Diagnosis, Research and Prevention provides a basic understanding of the current trends in rabies. It establishes a new facility for rabies surveillance, vaccine and antibody manufacturing.
Rupprecht, Charles Edward., Nagarajan, Thirumeni.   +1 more
core  

Immunogenicity of anti-rabies vaccines (ARVs) marketed in Sri Lanka: a comparative study. [PDF]

Clin Exp Vaccine Res
Rathnadiwakara H, Cliquet F, Wasniewski M, Thibault JC, Schereffer JL, Thammitiyagodage M, Ijas M, Samaranayake D, Gunatilake M.   +8 more
europepmc   +1 more source